BioAdvance News

Group K Diagnostics Raises $2 Million in Series A Funding

By WebmasterNovember 5, 2018November 1st, 2024No Comments

Group K Diagnostics Raises $2 Million in Series A Funding

Previous PostPalvella Therapeutics Announces FDA Fast Track Designation for PTX-022 for Treatment of Pachyonychia Congenita
Next PostOncora Medical teams up with oncologists at N.Y.'s largest health system